First human test of new drug VRG50635 completed
NCT ID NCT06286475
Summary
This was the first study in humans to test the safety and how the body processes the experimental drug VRG50635. It involved 22 healthy volunteers who received single or multiple doses. The main goals were to check for side effects and measure how the drug moves through and is eliminated from the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lincoln Celerion Inc.,
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.